News

The University of Minnesota today released new statistics about its technology commercialization successes covering fiscal year 2022, including a record number of startups created and patents issued by U.S. and foreign authorities to University inventors. 

Retinal exams are being evaluated as potential Alzheimer’s screening methods. UMN researchers Robert Vince and Swati More have developed and licensed one such technology that is showing promising results in early clinical trials. 

Minnesota startup competition MN Cup announced 27 finalists, which include UMN startups Q-rounds and BKB Floral Foam, Inc.

Yiannis Kaznessis shares how he turned his innovative lab research at the University into growing agricultural startup General Probiotics. 

UMN research team to work with UMN startup Vascudyne to prepare for human clinical trial of bioengineered blood vessels that grow with patients.

Star Tribune op-ed highlights the UMN Tech Comm team and economic importance of tech transfer.

Recent recipient of a $1 million SBIR grant and NovoClade founder Siba Das worked with several UMN programs, including the Venture Center and Discovery Launchpad, along his journey from scientist to startup executive.

12 startups participated in Walleye Tank, a life science pitch competition produced by UMN Tech Comm and the Mayo Clinic to highlight companies that are tackling challenging healthcare problems in unique ways. 

The University of Minnesota has launched 200 startup companies since 2006, a major milestone, and has been ranked first for technology transfer within the heartland, a 20-state region, and fifth among all US public universities.

Carrie Haskell-Luevano develops novel chemical compounds and molecular tools for healthcare applications.